NEW YORK (GenomeWeb News) – German regulators have cleared Hologic's $3.7 billion purchase of Gen-Probe, the two companies said today.

The deal, under which Hologic will pay $82.75 for each share of Gen-Probe stock, cleared US antitrust review last month and with clearance from Germany's Federal Cartel Office, required antitrust clearances have been received, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.